Previous 10 | Next 10 |
2024-03-07 08:05:19 ET More on Avid Bioservices Laughing Water Capital - Avid Bioservices: Substantial Future Earnings Power, Strong Competitive Position Avid Bioservices: Don't Miss The Bigger Picture Avid Bioservices says revenues for third quarter of fiscal 2024 w...
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today the pricing of $160 million aggregate principal amount of 7.00% Convertible Senior Notes due 2029 (the “...
2024-03-06 16:41:51 ET More on Avid Bioservices Laughing Water Capital - Avid Bioservices: Substantial Future Earnings Power, Strong Competitive Position Avid Bioservices: Don't Miss The Bigger Picture Avid Bioservices, Inc. (CDMO) Q2 2024 Earnings Call Transcript ...
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today that it intends to offer, subject to market conditions and other factors, $160 million aggregate principal amo...
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pha...
2024-02-14 14:11:46 ET More on Charles River, IQVIA, etc. Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript Medpace Holdings, Inc. (MEDP) Q4 2023 Earnings Call Transcript Medpace Holdings, Inc. 2023 Q4 - Results - Earnings Call Pre...
2024-02-08 09:55:00 ET Summary Avid Bioservices was by far our biggest loser in 2023. Avid recently issued an investor presentation that provides more insights into their late phase pipeline and backlog continues to grow. CDMO has proven that it is a good operator, and the pip...
2024-02-04 18:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-01 03:21:00 ET Summary Laughing Water Capital is a concentrated, long biased investment partnership open to accredited investors. Our interests are fully aligned with our partners as nearly all of our personal wealth is invested in our strategy. For Q4 2023, Class A intere...
2024-01-24 22:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
News, Short Squeeze, Breakout and More Instantly...
Avid Bioservices Inc. Company Name:
CDMO Stock Symbol:
NASDAQ Market:
Avid Bioservices Inc. Website:
-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and Gene Therapy Facilities Fully Operational and in Service; Capital Expenditur...
China Yuchai International Limited (CYD) is expected to report for Q1 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Derwent London Plc (DWVYF) is expected to report for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Basilea Pharmaceutic...
TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announc...